D-Dimer Combined with Fibrinogen Predicts the Risk of Venous Thrombosis in Fracture Patients

Table 1

Clinical characteristics of patients in VTE and non-VTE groups.

Variables	Non-VTE	VTE	value
Prothrombin international ratio	0.98 ± 0.12	1.01 ± 0.15	<0.0001
Partial thromboplastin time	29.50 ± 5.65	29.33 ± 5.80	0.4269
Thrombin time	19.42 ± 2.81	18.95 ± 2.52	<0.0001
Prothrombin time	11.63 ± 1.45	11.85 ± 1.81	0.0007
Total cholesterol	4.76 ± 1.17	4.57 ± 1.17	<0.0001
Triglyceride	1.46 ± 1.14	1.31 ± 0.97	<0.0001
C-reactive protein	21.93 ± 40.26	34.94 ± 46.39	<0.0001
D-dimer	1079.84 ± 2769.37	2505.34 ± 4086.32	<0.0001
Fibrinogen	3.04 ± 0.95	3.11 ± 0.98	0.0458
Blood platelet	244.84 ± 80.19	225.42 ± 80.21	<0.0001
Low-density lipoprotein cholesterol	2.59 ± 0.84	2.46 ± 0.83	<0.0001
High-density lipoprotein cholesterol	1.43 ± 0.43	1.42 ± 0.41	0.3346
Blood glucose	5.75 ± 1.85	6.18 ± 2.30	<0.0001
Age	55.68 ± 18.72	64.08 ± 16.65	<0.0001

VTE: venous thromboembolism